MSc Cell and Gene Therapies: from bench to bedside and Good Manufacturing Practices


    Τμήμα: ΙΑΤΡΙΚΗΣ

    Πόλη: ΠΑΤΡΑ

    Είδος ΠΜΣ: Διϊδρυματικό ΠΜΣ

    Παρακολούθηση: Πρακτική Άσκηση

    Διάρκεια Φοίτησης (Εξάμηνα): 2

    Γλώσσα Διδασκαλίας: Αγγλική

    Επιστημονικά Αντικείμενα: Υγεία και πρόνοια,Υγεία

    ΦΕΚ (Αριθμός Τεύχους): Τεύχος B’ 2572/16.06.2021

    Τέλη Φοίτησης: Με τέλη φοίτησης

    Ποσό Τελών Φοίτησης: 4000

    URL Ιστοσελίδας:

    Λήξη (π.χ. 2024-2025): 2031-2032

  • Περιγραφή Μεταπτυχιακού:

    WHY MSc Cell and Gene Therapies?

    Innovative and breakthrough topic

    Cell and gene therapies (CGTs) are at the forefront of modern advancements in health and they are expected to transform the landscape of biological medications, providing hope to unmet medical needs. CGT therapies are constantly added to the product portfolios of big pharma and biotech businesses, while regulators expect to authorize 10 to 20 CGT products per year by 2025.

    Prospects of industrial application

    In a field where the number of cell and gene therapy developers has grown by 90% since 2012 and health professionals’ employment needs are growing exponentially, prospects of achieving a career path in leading companies in the field are very high.

    Theory and practice

    A unique experience to get involved in CGT hands – on activities under real GMP lab conditions. Through the combination of theory and practice, students get engaged in direct application of skills, theories, and procedures related to development of CGT therapies.

    Invited Worldwide class speakers

    An assembly of experts in the field of CGTs will be presenting the lectures of the course, providing the opportunity to to be taught by those who lead this groundbreaking field and to gain as much knowledge as possible from specialists who have already attained mastery in the fields


    This is a bi-institutional program of postgraduate studies of the School of Medicine of the University of Patras and the Department of Biomedical Sciences of the University of West Attica. You can find the Government Gazette and the Regulation of Studies here

    The “MSc Cell and Gene Therapies” aims to provide high-level postgraduate education in the field of Advanced Therapeutic Medicinal Products (ATMPs) and especially of Cell and Gene Therapies (CGT).

    This program covers all aspects of cell and gene therapy with the purpose to train graduate scientists of various expertise in the fields of production, distribution, clinical evaluation and clinical implementation of CGTs and study both the biological substrate of CGTs and the regulatory framework for their production and their application. The course includes also training in basic cell biology, lab techniques and statistics. You may find the modules and the course objectives here

    The Value Proposition
    The master program will provide the students with a practical profession with high market demand. The high-level training of health and bio related scientists will empower their skills towards employability as executives in private or public sectors in the areas of Biotechnology and Health and scientists with medical direction will be trained in the fields of CGT clinical research, translation research and their application for treatment of incurable diseases. MSc graduates may proceed to PhD studies.

    Teaching Methods:
    Face to face and on-line lectures and seminars, virtual reality training, individual and group assignments, practical training in GMP Labs of industrial partners (Theracell) or of the Institute of Cell Therapy “Dimitris Lois”, Univeristy of Patras (here)

    An international assembly of experts who lead this groundbreaking field of CGTs will be providing lectures and seminars. See the list of lecturers here

    Graduate Degree
    MSc in «Cell and Gene Therapies: from bench to bedside and Good Manufacturing Practices» awarded from University of Patras and University of West Attica

  • Απευθύνεται σε απόφοιτους των τμημάτων:

    Target audience
    Students with a bachelor degree in life sciences or equivalent interested in a role in the C> field in academic, clinical, industrial and regulatory settings. You may find the entry requirements and the selection process here

    Entry Requirements

    Applications for academic year 2021-2022 admission will start from November 2021. The selection will be completed and announced by January 2022, as lectures will officially start on the 23rd of February 2022. The required supporting documents are here.
    Prerequisites: Graduates of Medicine, Pharmacy, Biology, Molecular Biology, Biomedicine, Science, Chemistry, Biochemistry, Chemical Engineering, Medical Laboratories, or similar degrees.

    The selection of the participants is made by the evaluation committee mainly with consideration of:

    • the final grade of the Bachelor’s Degree
    • the grades in undergraduate courses which are related to the subject of the MSc
    • the relevance and grade of the Bachelor’s thesis
    • the candidate ‘s research and professional activity
    • the English language proficiency
    • the performance during the interview

  • Ειδικεύσεις:

    Το Δ. Π.Μ.Σ. απονέμει Δίπλωμα Μεταπτυχιακών Σπουδών (Δ.Μ.Σ.) στην «Cell and Gene Therapies: from bench to bedside and Good Manufacturing Practices».
    Ο μεταπτυχιακός τίτλος είναι ενιαίος και απονέμεται από κοινού από τα συνεργαζόμενα ιδρύματα.

  • Συνεργαζόμενα Τμήματα:

    University of West Attica (Τμήμα Βιοϊατρικών Επιστημών του Πανεπιστημίου Δυτικής Αττικής)

  • Σημειώσεις:



    School of Medicine
    University of Patras

    University Campus, 26504 Rio Achaia


    Ms. Aikaterini Michalopoulou

    Tel +30-2610969106


    University of West Attika
    Department of Biomedical Sciences

    University Campus, Agiou Spyridonos 28
    12243 Egaleo


    Tel +30 2610 969 100 – 969 108

    +30 210 5385 100